Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Quadrivalent Meningococcal Vaccine market was valued at US$ 190.4 million in 2022 and is projected to reach US$ 279.3 million by 2029, at a CAGR of 5.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Many countries have implemented meningococcal vaccination programs, especially targeting high-risk groups such as infants, adolescents and university students. Inclusion or recommendation of quadrivalent meningococcal vaccines in national immunization schedules can significantly influence the market demand.
The meningococcal quadrivalent vaccine protects against 4 types of meningococcus: types A, C, Y, and W.
This report aims to provide a comprehensive presentation of the global market for Quadrivalent Meningococcal Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Quadrivalent Meningococcal Vaccine. This report contains market size and forecasts of Quadrivalent Meningococcal Vaccine in global, including the following market information:
Global Quadrivalent Meningococcal Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Quadrivalent Meningococcal Vaccine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Quadrivalent Meningococcal Vaccine companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Quadrivalent Meningococcal Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Quadrivalent Meningococcal Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Quadrivalent Meningococcal Vaccine Market Segment Percentages, by Type, 2022 (%)
Polysaccharide Vaccine
Conjugate Vaccine
Global Quadrivalent Meningococcal Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Quadrivalent Meningococcal Vaccine Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Global Quadrivalent Meningococcal Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Quadrivalent Meningococcal Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Quadrivalent Meningococcal Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Quadrivalent Meningococcal Vaccine revenues share in global market, 2022 (%)
Key companies Quadrivalent Meningococcal Vaccine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Quadrivalent Meningococcal Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi-Pasteur
Walvax
Chengdu Kanghua Biological Products Co., Ltd.
Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.
Zhejiang Tianyuan Biopharmaceutical Co., Ltd.
Beijing Institute of Biological Products Co., Ltd.
CanSino Biological Co., Ltd.
Hualan Biological Vaccine Co., Ltd.
Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Quadrivalent Meningococcal Vaccine, market overview.
Chapter 2: Global Quadrivalent Meningococcal Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Quadrivalent Meningococcal Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Quadrivalent Meningococcal Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Quadrivalent Meningococcal Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Quadrivalent Meningococcal Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Quadrivalent Meningococcal Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Quadrivalent Meningococcal Vaccine Overall Market Size
2.1 Global Quadrivalent Meningococcal Vaccine Market Size: 2022 VS 2029
2.2 Global Quadrivalent Meningococcal Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Quadrivalent Meningococcal Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Quadrivalent Meningococcal Vaccine Players in Global Market
3.2 Top Global Quadrivalent Meningococcal Vaccine Companies Ranked by Revenue
3.3 Global Quadrivalent Meningococcal Vaccine Revenue by Companies
3.4 Global Quadrivalent Meningococcal Vaccine Sales by Companies
3.5 Global Quadrivalent Meningococcal Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Quadrivalent Meningococcal Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Quadrivalent Meningococcal Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Quadrivalent Meningococcal Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Quadrivalent Meningococcal Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Quadrivalent Meningococcal Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Quadrivalent Meningococcal Vaccine Market Size Markets, 2022 & 2029
4.1.2 Polysaccharide Vaccine
4.1.3 Conjugate Vaccine
4.2 By Type - Global Quadrivalent Meningococcal Vaccine Revenue & Forecasts
4.2.1 By Type - Global Quadrivalent Meningococcal Vaccine Revenue, 2018-2023
4.2.2 By Type - Global Quadrivalent Meningococcal Vaccine Revenue, 2024-2029
4.2.3 By Type - Global Quadrivalent Meningococcal Vaccine Revenue Market Share, 2018-2029
4.3 By Type - Global Quadrivalent Meningococcal Vaccine Sales & Forecasts
4.3.1 By Type - Global Quadrivalent Meningococcal Vaccine Sales, 2018-2023
4.3.2 By Type - Global Quadrivalent Meningococcal Vaccine Sales, 2024-2029
4.3.3 By Type - Global Quadrivalent Meningococcal Vaccine Sales Market Share, 2018-2029
4.4 By Type - Global Quadrivalent Meningococcal Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Quadrivalent Meningococcal Vaccine Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Quadrivalent Meningococcal Vaccine Revenue & Forecasts
5.2.1 By Application - Global Quadrivalent Meningococcal Vaccine Revenue, 2018-2023
5.2.2 By Application - Global Quadrivalent Meningococcal Vaccine Revenue, 2024-2029
5.2.3 By Application - Global Quadrivalent Meningococcal Vaccine Revenue Market Share, 2018-2029
5.3 By Application - Global Quadrivalent Meningococcal Vaccine Sales & Forecasts
5.3.1 By Application - Global Quadrivalent Meningococcal Vaccine Sales, 2018-2023
5.3.2 By Application - Global Quadrivalent Meningococcal Vaccine Sales, 2024-2029
5.3.3 By Application - Global Quadrivalent Meningococcal Vaccine Sales Market Share, 2018-2029
5.4 By Application - Global Quadrivalent Meningococcal Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Quadrivalent Meningococcal Vaccine Market Size, 2022 & 2029
6.2 By Region - Global Quadrivalent Meningococcal Vaccine Revenue & Forecasts
6.2.1 By Region - Global Quadrivalent Meningococcal Vaccine Revenue, 2018-2023
6.2.2 By Region - Global Quadrivalent Meningococcal Vaccine Revenue, 2024-2029
6.2.3 By Region - Global Quadrivalent Meningococcal Vaccine Revenue Market Share, 2018-2029
6.3 By Region - Global Quadrivalent Meningococcal Vaccine Sales & Forecasts
6.3.1 By Region - Global Quadrivalent Meningococcal Vaccine Sales, 2018-2023
6.3.2 By Region - Global Quadrivalent Meningococcal Vaccine Sales, 2024-2029
6.3.3 By Region - Global Quadrivalent Meningococcal Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Quadrivalent Meningococcal Vaccine Revenue, 2018-2029
6.4.2 By Country - North America Quadrivalent Meningococcal Vaccine Sales, 2018-2029
6.4.3 US Quadrivalent Meningococcal Vaccine Market Size, 2018-2029
6.4.4 Canada Quadrivalent Meningococcal Vaccine Market Size, 2018-2029
6.4.5 Mexico Quadrivalent Meningococcal Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Quadrivalent Meningococcal Vaccine Revenue, 2018-2029
6.5.2 By Country - Europe Quadrivalent Meningococcal Vaccine Sales, 2018-2029
6.5.3 Germany Quadrivalent Meningococcal Vaccine Market Size, 2018-2029
6.5.4 France Quadrivalent Meningococcal Vaccine Market Size, 2018-2029
6.5.5 U.K. Quadrivalent Meningococcal Vaccine Market Size, 2018-2029
6.5.6 Italy Quadrivalent Meningococcal Vaccine Market Size, 2018-2029
6.5.7 Russia Quadrivalent Meningococcal Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Quadrivalent Meningococcal Vaccine Market Size, 2018-2029
6.5.9 Benelux Quadrivalent Meningococcal Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Quadrivalent Meningococcal Vaccine Revenue, 2018-2029
6.6.2 By Region - Asia Quadrivalent Meningococcal Vaccine Sales, 2018-2029
6.6.3 China Quadrivalent Meningococcal Vaccine Market Size, 2018-2029
6.6.4 Japan Quadrivalent Meningococcal Vaccine Market Size, 2018-2029
6.6.5 South Korea Quadrivalent Meningococcal Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Quadrivalent Meningococcal Vaccine Market Size, 2018-2029
6.6.7 India Quadrivalent Meningococcal Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Quadrivalent Meningococcal Vaccine Revenue, 2018-2029
6.7.2 By Country - South America Quadrivalent Meningococcal Vaccine Sales, 2018-2029
6.7.3 Brazil Quadrivalent Meningococcal Vaccine Market Size, 2018-2029
6.7.4 Argentina Quadrivalent Meningococcal Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Quadrivalent Meningococcal Vaccine Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Quadrivalent Meningococcal Vaccine Sales, 2018-2029
6.8.3 Turkey Quadrivalent Meningococcal Vaccine Market Size, 2018-2029
6.8.4 Israel Quadrivalent Meningococcal Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Quadrivalent Meningococcal Vaccine Market Size, 2018-2029
6.8.6 UAE Quadrivalent Meningococcal Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sanofi-Pasteur
7.1.1 Sanofi-Pasteur Company Summary
7.1.2 Sanofi-Pasteur Business Overview
7.1.3 Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Major Product Offerings
7.1.4 Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 Sanofi-Pasteur Key News & Latest Developments
7.2 Walvax
7.2.1 Walvax Company Summary
7.2.2 Walvax Business Overview
7.2.3 Walvax Quadrivalent Meningococcal Vaccine Major Product Offerings
7.2.4 Walvax Quadrivalent Meningococcal Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Walvax Key News & Latest Developments
7.3 Chengdu Kanghua Biological Products Co., Ltd.
7.3.1 Chengdu Kanghua Biological Products Co., Ltd. Company Summary
7.3.2 Chengdu Kanghua Biological Products Co., Ltd. Business Overview
7.3.3 Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Major Product Offerings
7.3.4 Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Chengdu Kanghua Biological Products Co., Ltd. Key News & Latest Developments
7.4 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.
7.4.1 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Company Summary
7.4.2 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Business Overview
7.4.3 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Major Product Offerings
7.4.4 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Key News & Latest Developments
7.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd.
7.5.1 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Company Summary
7.5.2 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Business Overview
7.5.3 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Major Product Offerings
7.5.4 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Key News & Latest Developments
7.6 Beijing Institute of Biological Products Co., Ltd.
7.6.1 Beijing Institute of Biological Products Co., Ltd. Company Summary
7.6.2 Beijing Institute of Biological Products Co., Ltd. Business Overview
7.6.3 Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Major Product Offerings
7.6.4 Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 Beijing Institute of Biological Products Co., Ltd. Key News & Latest Developments
7.7 CanSino Biological Co., Ltd.
7.7.1 CanSino Biological Co., Ltd. Company Summary
7.7.2 CanSino Biological Co., Ltd. Business Overview
7.7.3 CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Major Product Offerings
7.7.4 CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 CanSino Biological Co., Ltd. Key News & Latest Developments
7.8 Hualan Biological Vaccine Co., Ltd.
7.8.1 Hualan Biological Vaccine Co., Ltd. Company Summary
7.8.2 Hualan Biological Vaccine Co., Ltd. Business Overview
7.8.3 Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Major Product Offerings
7.8.4 Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 Hualan Biological Vaccine Co., Ltd. Key News & Latest Developments
7.9 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.
7.9.1 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Company Summary
7.9.2 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Business Overview
7.9.3 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Major Product Offerings
7.9.4 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Key News & Latest Developments
8 Global Quadrivalent Meningococcal Vaccine Production Capacity, Analysis
8.1 Global Quadrivalent Meningococcal Vaccine Production Capacity, 2018-2029
8.2 Quadrivalent Meningococcal Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Quadrivalent Meningococcal Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Quadrivalent Meningococcal Vaccine Supply Chain Analysis
10.1 Quadrivalent Meningococcal Vaccine Industry Value Chain
10.2 Quadrivalent Meningococcal Vaccine Upstream Market
10.3 Quadrivalent Meningococcal Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Quadrivalent Meningococcal Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
